box-sizing: border-box;">
M129297Mirtazapine | ≥98% | 85650-52-8 | 100mg,1g | | 5-HT | | | | | SB742457 | SB742457 | ≥97% | 607742-69-8 | 5mg,25mg | | 5-HT6 | | | 9.63 |
| B129690 | BRL-15572 | ≥99% | 193611-72-2 | 5mg,10mg,50mg | | 5-HT1D | | | 7.9 |
| P129785 | PRX-08066 Maleic acid | ≥99% | 866206-55-5 | 5mg,10mg,50mg | | 5-HT2B | 3.4 nM | | |
| T124762 | 盐酸托烷司琼 | ≥98.0% | 105826-92-4 | 250mg,1g,5g | | 5-HT3 | 70.1±0.9 nM | | |
| P129438 | Pizotifen Malate | ≥99% | 5189-11-7 | 100mg,500mg | | | | | |
| A129701 | Azasetron HCl | ≥99% | 123040-16-4 | 25mg,100mg | | 5-HT3 | 0.33 nM | | |
| F129636 | 夫洛丙酮 | ≥99% | 2295-58-1 | 50mg | | 5-HT1A | | | |
| O129694 | Ondansetron | ≥99% | 99614-02-5 | 10mg,50mg,250mg | | 5-HT3 | | | |
| P129744 | Palonosetron HCl | ≥99% | 135729-62-3 | 100mg,500mg | | 5-HT3 | | | |
| V129763 | VUF 10166 | ≥99% | 155584-74-0 | 10mg,50mg,250mg | | 5-HT3A | | 0.04 nM | |
| 5-HT3AB | | 22 nM | |
| N159830 | 奈法唑酮盐酸盐 | 98.00% | 82752-99-6 | 200mg,1g | | | | | |
| C101491 | 盐酸赛庚啶 | 98% | 41354-29-4 | 1g,5g,25g | | 5-HT2 | | 0.6 nM | |
| O129679 | Ondansetron Hydrochloride Dihydrate | ≥98% (HPLC) | 103639-04-9 | 1g,5g | | 5-HT3 receptor | | 6.16 nM | |
| A135530 | Alosetron Hydrochloride | ≥98% (HPLC) | 122852-69-1 | 1g,5g | | 5-HT3 receptor | | | |
| S132232 | Sarpogrelate Hydrochloride | ≥98% | 135159-51-2 | 5mg,25mg,100mg | | 5-HT2A | | | 8.52 |
| 5-HT2C | | | 7.43 |
| 5-HT2B | | | 6.57 |
| R166990 | Ramosetron hydrochloride | 98% (HPLC) | 132907-72-3 | 10mg,50mg,100mg,250mg | | 5-HT3 receptor | | 0.091 nM | |
| P111270 | 葛根素 | 98% | 3681-99-0 | 1g,5g,25g,100g | | 5-HT2C | | | |
| P111269 | 葛根素 | 分析标准品,≥98% | 3681-99-0 | 20mg | | 5-HT2C | | | |
| C134704 | Cyclobenzaprine hydrochloride | 98% | 6202-23-9 | 1g,5g,25g | | 5-HT2 receptor | | | |
| G127257 | Granisetron | - | 109889-09-0 | 25mg,50mg,100mg,250mg | | 5HT-3 | | | |
| L129692 | LY310762 | ≥95% | 192927-92-7 | 10mg,50mg | | 5-HT1D | 249 nM | | |
| P125293 | Palonosetron | - | 135729-61-2 | 10mg,100mg | | 5-HT3 receptor | | 0.17 nM | |
| M124574 | 5-甲氧基色胺 | 97% | 608-07-1 | 250mg,1g,5g,25g | | 5-HT1 | | | |
| 5-HT2 | | | |
| 5-HT4 | | | |
| 5-HT6 | | | |
| S129681 | Sumatriptan Succinate | ≥98% (HPLC) | 103628-48-4 | 50mg,100mg,250mg,1g | | | | | |
| P129662 | Prucalopride | ≥99% | 179474-81-8 | 10mg,50mg | | 5-HT4A | | 2.5 nM | |
| 5-HT4B | | 8 nM | |
| A124880 | Aripiprazole | ≥99% | 129722-12-9 | 1g,5g | | 5-HT1A | | 4.2 nM | |
| N129630 | Naratriptan hydrochloride | ≥98% | 143388-64-1 | 10mg,25mg,50mg,100mg | | 5-HT | | | |
| R129638 | Rizatriptan Benzoate | ≥98%(HPLC) | 145202-66-0 | 10mg,50mg,250mg,1g,5g | | 5-HT1 | | | |
| Z129649 | Zolmitriptan | ≥98%(HPLC) | 139264-17-8 | 200mg,250mg,1g,5g,25g | | 5-HT | | | |
| M129673 | Mosapride Citrate | ≥98% | 112885-42-4 | 10mg,50mg,250mg,1g,5g,25g | | 5-HT4 | | | |
| E129729 | Eletriptan HBr | ≥98% | 177834-92-3 | 10mg,50mg,250mg,1g,5g | | 5-HT1B | | 0.92 nM | |
| 5-HT1D | | 3.14 nM | |
| A129703 | Almotriptan Malate | ≥99% | 181183-52-8 | 1g | | 5-HT1B | | | |
| 5-HT1D | | | |
| T168187 | Tegaserod maleate | 98% (HPLC) | 189188-57-6 | 10mg,50mg | | 5-HT4 receptor | | | |
| B129734 | BRL-54443 | ≥98% | 57477-39-1 | 10mg,50mg,100mg | | 5-HT1E | | | 8.7 |
| 5-HT1F | | | 9.25 |
| B178171 | brexpiprazole | 97% | 913611-97-9 | 1g | | D2L | | 0.3 nM | |
| 5-HT1A | | 0.12 nM | |
| 5-HT2A | | 0.47 nM | |
| α1B受体 | | 0.17 nM | |
| α2C受体 | | 0.59 nM | |
| M179481 | Mosapride | 95% | 112885-41-3 | 1g,5g | | 5HT4 | | | |
| S111161 | 血清胺盐酸盐 | AR | 153-98-0 | 1g,5g,25g | | 5-HT | | | |
| V124992 | Vilazodone | ≥98% | 163521-12-8 | 10mg,50mg | | | | | |
| F167802 | Flibanserin | 98% (HPLC) | 167933-07-5 | 5mg,25mg | | 5-HT1A | | 1 nM | |
| 5-HT2A | | 49 nM | |
| F167802 | Vortioxetine | ≥98% | 508233-74-7 | 10mg,50mg,250mg,1g | | | | | |
| P129402 | Azacyclonol | ≥99% | 115-46-8 | 50mg | | | | | |
*肾上腺素受体
| 项目号 | 产品名称 | 规格 | CAS | 包装 | 靶点 | IC50 | Ki | pKi | Kd | EC50 | ED50 | pEC50 |
|---|
| D129796 | 甲磺酸多沙唑嗪 | ≥99% | 77883-43-3 | 50mg,100mg,250mg,1g,5g,25g,100g | α-1肾上腺素能受体 | | | | | | | |
| I129899 | Ivabradine HCl | ≥98% | 148849-67-6 | 250mg,1g,5g | 肾上腺素受体 | 2.9 μM | | | | | | |
| C129903 | Cisatracurium Besylate | ≥98% | 96946-42-8 | 1g | 肾上腺素受体 | | | | | | | |
| A124739 | Asenapine maleate | ≥98% (HPLC) | 85650-56-2 | 10mg,50mg,250mg,1g | 5-HT2C | | | 10.46 | | | | |
| 5-HT2A | | | 10.15 | | | | |
| 5-HT7 | | | 9.94 | | | | |
| 5-HT2B | | | 9.75 | | | | |
| 5-HT6 | | | 9.6 | | | | |
| C141489 | 卡拉洛尔 | 98% | 57775-29-8 | 250mg,1g | | | | | | | | |
| C120231 | 卡拉洛尔 | 分析标准品 | 57775-29-8 | 10mg | | | | | | | | |
| A129804 | Alfuzosin hydrochloride | ≥98% | 81403-68-1 | 50mg,100mg,250mg,1g | α1受体 | | | | | | | |
| S126595 | Silodosin | ≥99% | 160970-54-7 | 5mg,25mg,100mg,250mg,1g | | | | | | | | |
| N129836 | Nebivolol hydrochloride | ≥97% | 152520-56-4 | 10mg,20mg,100mg,1g,5g | β1-肾上腺素受体 | 0.8 nM | |
地 址： 上海市新金桥路36号财富中心16楼
联系人： 阿博士
电 话： 400-620-6333
传 真： 021-50323701
Email：market@aladdin-e.com
【阿拉丁】EBL-3183的工艺之路：从吲哚到临床前抑制剂
(暂无发布时间 浏览数:8172)
【阿拉丁】蛋白质印迹的上样对照
(2024-05-15T00:00 浏览数:9657)
【阿拉丁】ROS1 融合抑制剂NVL-520与MGAT2 抑制剂 BMS-963272
(2024-05-14T00:00 浏览数:9512)
【阿拉丁】胶体金在电子显微镜领域的应用
(2024-05-13T00:00 浏览数:9725)
【阿拉丁】纳米颗粒用于共振成像造影剂
(2024-05-11T00:00 浏览数:10474)
【阿拉丁】GDC-1971——SHP2抑制剂引领癌症治疗新纪元
(2024-04-28T00:00 浏览数:10342)
【阿拉丁】新药研发中的点击化学
(2024-04-25T00:00 浏览数:12521)
【限时免费！】领取阿拉丁生物产品试用装，超值体验蛋白和抗体！
(暂无发布时间 浏览数:10782)
【阿拉丁试剂】1,3-噻唑砌块在天然产物和合成材料中的应用
(2024-04-23T00:00 浏览数:11670)
【阿拉丁试剂】免疫细胞化学染色实验方案
(2024-04-22T00:00 浏览数:11562)
|
